We have the same issue and have now wriien to the liquyidators of DH2 (UK) Limited to see what response we get, not hopeful.
If the note from the liquidators is correct that Direct Health paid the phama company for the mumps vacinations and these were never supplied this may have other implications.
I know that like many other distressed parents we will not have a child not fully vacinated due to this. Could we get a class action for distress with a no win no fee case against the drug company who have not supplied the drug?
Just a thought i know the US are very stong on supporting things like this. It would be a case for distress caused rather than the cost of the vacination in my view.
The website statement is below:
If the note from the liquidators is correct that Direct Health paid the phama company for the mumps vacinations and these were never supplied this may have other implications.
Obviously
STOP PRESS
The directors of DH2 (UK) Limited (?the Company?) have instructed Neil Gibson and Mark Tailby of CBA to place the Company into Creditors? Voluntary Liquidation. Please see the letter to All Known Creditors dated 30 November 2009 under Health News on this site for further information. There is also a Proof of Debt Form under Health News.
If you have paid for a vaccination by credit card which you have not received, you may be able to claim a refund from your credit card provider. Please contact your card issuer. Alternatively, complete the attached Proof of Debt Form and return to the office address below to register your claim against the Company.
Should you have any queries, or are a creditor, please write to the address below or send an email to [email protected]
CBA
39 Castle Street
Leicester
LE1 5WN
Company Statement
Details of any major problem areas e.g. bad contracts, lost contracts, cash flow, competition, dh2uk failed due to many reasons. Its prime market was middle class families requiring the single component vaccines for measles mumps and rubella as opposed to the NHS provided combined vaccine of the MMR.
Since the economic decline and crisis that followed in 2009, many families have been umable to afford to continue their course with dh2uk and demand dropped quite markedly. Further more, the sole mumps vaccine manufacturer, Merck in the USA, as recent as October announced that it was no longer manufacturing the single vaccine for mumps. This led to an untenable situation for the company as many parents would be forced to have the MMR combined vaccine and uptake for the single vaccines would dwindle to nothing.
Merck have always made the single component mumps vaccine and have to make all three components of the MMR separately, but they are now not going to "bottle" the components separately. I believe this to be a deliberate ploy by Merck in an attempt to boost sales of their combined vaccine and to deny choice to parents who wish to have the vaccines administered separately.
It is also the wish of the Department of Health in this country to deny access to the single vaccines as they are insistent that they are not as effective as the combined vaccine when there is strong evidence to prove otherwise. The DOH and its leaders have threatened to resign if single vaccines became part of the vaccine schedule in this country and, I believe that the DOH had a lot to do with the decision of Merck not to make the mumps vaccine anymore. dh2uk had also asked on numerous occasions for an alternative vaccine to be imported under license from the MHRA, but was denied access to this vaccine on professed grounds of safety, even though the vaccine had a proven safety record and a better efficacy.
dh2uk failed due to inherent government body meddling, the economic climate and the loss of source of a major vaccine due to refusal of the pharmaceutical company to make it available, even though it had promised our supplier delivery on seven different occasions in 2009, even giving dates that were then not honoured. By the very nature of the pharmaceutical business, all vaccines have to be paid for in advance and. dh2uk had paid deposits to other suppliers which have not been returned.
The other major reason that dh2uk failed was due to the fact that it honoured outstanding vaccines to parents of the old company Direct Health 2000 Ltd, and it had also refunded some parents' money for mumps vaccine and carried over these "dues" at a financial loss to itself in the spirit of decency and the right thing to do.
Sarah Dean
Director, DH2 (UK) Limited